GlassScriptPhysician profile
Jonathan K Jay
NPI 1225088305
$27,698.06
in general payments reported to CMS, 2019-2025
58 companies · $5,047 in 2025
The $5,047 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,024 · 2020: $5,738 · 2021: $3,787 · 2022: $1,946 · 2023: $2,938 · 2024: $5,219 · 2025: $5,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,399 · Consulting Fee: $3,000 · Travel and Lodging: $2,650 · Education: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,398.64 |
| Consulting Fee | $3,000.00 |
| Travel and Lodging | $2,649.93 |
| Education | $154.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $5,816.27 | 2020-2024 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $4,325.20 | 2020-2021 | |
| Bioprotect Medical, INC. | $3,171.05 | 2024-2025 | Bioprotect Balloon Implant System |
| Astellas Pharma US INC | $1,608.25 | 2019-2025 | Xtandi |
| Boston Scientific Corporation | $1,305.75 | 2019-2025 | Axonics, Spaceoar Vue System - 10ml, Ams 700 |
| Neotract INC. | $1,277.23 | 2019-2020 | |
| Teleflex LLC | $1,107.34 | 2021-2025 | Urolift, Barrigel, Solesta |
| Procept Biorobotics Corporation | $929.01 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Pfizer INC. | $660.22 | 2019-2025 | |
| Janssen Biotech, INC. | $606.29 | 2019-2025 | Erleada |
| Abbvie INC. | $604.42 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $549.41 | 2019-2025 | Provenge |
| Urogen Pharma, INC. | $476.66 | 2021-2025 | Jelmyto |
| Ferring Pharmaceuticals INC. | $341.59 | 2019-2025 | Adstiladrin |
| Blue Earth Diagnostics | $329.73 | 2019-2024 |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $323.74 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $315.76 | 2021-2024 | Prolaris, Precisetumor |
| Endo Pharmaceuticals INC. | $315.45 | 2019-2023 | Edex, Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $266.62 | 2020-2024 | Lynparza |
| Merck Sharp & Dohme LLC | $248.55 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Sumitomo Pharma America, INC. | $247.60 | 2023-2025 | Gemtesa, Orgovyx |
| Srs Medical Systems, INC. | $218.17 | 2019-2020 | |
| Valencia Technologies Corporation | $193.69 | 2024-2025 | Ecoin Device Kit |
| Allergan, INC. | $165.29 | 2019-2022 | |
| Amgen INC. | $151.76 | 2019-2023 | Xgeva |
| Laborie Medical Technologies Corp. | $149.55 | 2022-2025 | Optilume Bph Drug Coated Balloon Catheter, Aquarius Lt |
| Coloplast Corp | $141.47 | 2019-2025 | |
| Tolmar Pharmaceuticals, INC. | $136.59 | 2020-2022 | |
| Uromedica, Incorporated | $134.00 | 2019 | |
| Profound Medical Corp. | $121.60 | 2022-2023 | Tulsa-Pro |
| Tolmar, INC. | $107.27 | 2023-2025 | Jatenzo, Eligard |
| Rochester Medical Corporation | $100.43 | 2019-2022 | |
| Medtronic USA, INC. | $96.57 | 2020 | |
| Endo USA, INC. | $95.88 | 2024-2025 | Xiaflex, Aveed, Edex |
| C. R. Bard, INC. & Subsidiaries | $92.92 | 2019-2020 | |
| Myovant Sciences INC. | $91.08 | 2021-2022 | |
| Antares Pharma, INC. | $89.18 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Olympus America INC. | $84.73 | 2022-2025 | Itind System |
| Ambu INC. | $84.05 | 2021-2022 | |
| Urogpo LLC | $70.19 | 2020 | |
| Sun Pharmaceutical Industries INC. | $69.90 | 2019-2024 | |
| Accord Healthcare, INC. | $65.82 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $64.51 | 2022-2025 | |
| Bluewind Medical | $51.93 | 2025 | |
| Alnylam Pharmaceuticals INC. | $41.67 | 2021-2022 | |
| Urovant Sciences INC | $37.85 | 2022 | |
| Dentsply Ih INC. | $31.47 | 2022 | |
| Becton, Dickinson and Company | $25.98 | 2025 | Bard Urinary Drainage Bag |
| 180 Medical, INC. | $24.19 | 2022 | |
| Verity Pharmaceuticals INC. | $22.10 | 2025 | Trelstar |
| Therapeuticsmd, INC. | $21.57 | 2019 | |
| Halozyme INC | $19.84 | 2023 | |
| Travere Therapeutics, INC. | $17.39 | 2020 | |
| Medtronic, INC. | $16.26 | 2021 | |
| Tempus Ai, INC | $13.70 | 2025 | Xt Cdx |
| Bard Access Systems, INC. | $12.03 | 2019 | |
| Mission Pharmacal Company | $11.29 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$66,817.72 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Jay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.